BUSINESS SEGMENT INFORMATION (Tables)

9 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Product Revenues [Table Text Block]

Product revenues and the composition of total revenues were as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
Dollars in Millions	2017		2016		2017		2016
Prioritized Brands
Opdivo	$	1,265	$	920	$	3,587	$	2,464
Eliquis	1,232		884		3,509		2,395
Orencia	632		572		1,817		1,640
Sprycel	509		472		1,478		1,330
Yervoy	323		285		975		789
Empliciti	60		41		168		103
Established Brands
Hepatitis C Franchise	73		379		347		1,352
Baraclude	264		306		819		896
Sustiva Franchise	183		275		555		819
Reyataz Franchise	174		238		555		706
Other Brands	539		550		1,517		1,690
Total Revenues	$	5,254	$	4,922	$	15,327	$	14,184
Net product sales	$	4,862	$	4,492	$	14,212	$	12,888
Alliance revenues	334		402		957		1,229
Other revenues	58		28		158		67
Total Revenues	$	5,254	$	4,922	$	15,327	$	14,184